Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ELV vs GSK✓SelectedUSD · GSKELV vs GSK performance historyLatest closeAs of+1.11%11/20
Stock and ETF performance explorer

ELV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-10.9%
GSK return
+53.4%
Excess return
-64.2%
Maximum drawdown
-50.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%-0.1%+1.2%+1.1%
7D-8.2%-5.3%-2.9%-6.6%
30D-9.1%-3.7%-5.5%-8.1%
3M0.0%-7.3%+7.2%+2.1%
6M+0.4%-4.2%+4.6%+1.2%
YTD+14.2%+0.9%+13.3%+12.1%
1Y+28.1%+7.3%+20.9%+22.9%
3Y-10.9%+52.7%-63.6%-27.9%
All-10.9%+53.4%-64.2%-27.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling